The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2017T Cell-mediated Autoimmune Responses in Parkinson's Disease
Study Rationale
The protein alpha-synuclein, which is misprocessed in nearly every case of Parkinson's disease (PD), forms the Lewy bodies seen in PD patient brain. In our recent MJFF-funded study, our... -
Research Grant, 2017Using Immune Cells to Treat Parkinson's Disease
Study Rationale:
While significant strides have been made toward therapies that can prevent, slow or stop Parkinson's disease (PD) progression, no currently approved Parkinson's treatment can do this... -
Access to Data and Biospecimens, 2017An 8-protein panel for diagnosis of Parkinson’s Disease: Sample request for replication in PDBP and PPMI
Study Rationale:
We have previously found a panel of 8 proteins that can be measured in the blood that together distinguish people who have Parkinson’s Disease vs. people who do not. We are trying to...
-
Research Grant, 2017Inflammatory Parkinson's Clinical Biomarker Profiling
Study Rationale:
This study aims to compare the immune system of Parkinson's disease (PD) patients and their caregivers in an effort to determine differences between these groups. Several recently... -
LRRK2 Biology Consortium, 2017The Role of Variations in the LRRK2 Gene in Parkinson's Disease
Study Rationale:
Genes can influence one's chance of developing Parkinson's disease (PD), but it's not entirely clear how. In this study, we will use cells from people with Parkinson's to test how the... -
Access to Data and Biospecimens, 2017LRRK2 in predicting Parkinson disease risk and progression in LRRK2 mutation carriers
Study Rationale:
The G2019S mutation in the LRRK2 gene is responsible for thousands Parkinson disease (PD) cases. But, not all of the mutation carriers will develop PD. Currently, clinicians...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.